Clinical Trial Update: As Study of the Pharmacokinetics of Paliperidone Extended-release and Risperidone Immediate-release Formulations [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study comparing paliperidone Extended-Release with risperidone Immediate-Release in adults with Schizophrenia or Schizoaffective disorde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Paliperidone Extended Release (paliperidone extended-release)
• Risperidone Immediate-release (risperidone)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 1 | Status: COMPLETED